Chlamydia infection and respiratory disorders
InterCollegas. - Vol. 1, N1, 2014
PDF

How to Cite

Kuznetcov, S., Kucherenko, O., Zharkova, T., & Kucherenko, M. (2014). Chlamydia infection and respiratory disorders. Inter Collegas, 1(1), 116-131. https://doi.org/10.35339/ic.1.1.116-131

Abstract

CHLAMYDIA INFECTION AND RESPIRATORY DISORDERS Kuznetcov S., Kucherenko O., Zharkova T., Kucherenko M. Kharkiv national medical university, Kharkiv, Ukraine Abstract. Three chlamydial organisms are pathogenic to humans: C.pneumoniae, C.psittaci, and C.trachomatis. Clinical picture of chlamidiosis determine by species of the microbe. Efficiency of the treatment depends on timely and adequate therapy. Keywords: Chlamydia, pneumonia, infection. ХЛАМІДІНА ІНФЕКЦІЯ ТА РЕСПІРАТОРНІ ЗАХВОРЮВАННЯ Кузнєцов С.В., Кучеренко О.О., Жаркова Т.С., Кучеренко М.В. Харківський національний медичний університет, м. Харків, Україна Резюме. Розрізнюють три види хламідій: C.psitacci, C.рneumoniaе, C.trahomatis. Клінічна картина хламідіоза визначається видом збудника. Ефективність лікування залежить від своєчасної та адекватної терапевтичної тактики. Ключові слова: хламідія, пневмонія, інфекція. ХЛАМИДИЙНАЯ ИНФЕКЦИЯ И РЕСПИРАТОРНЫЕ ЗАБОЛЕВАНИЯ Кузнецов С.В., Кучеренко Е.О., Жаркова Т.С., Кучеренко М.В. Харьковский национальный медицинский университет, г. Харьков, Украина Резюме. Различают три вида хламидий: C.psitacci, C.рneumoniaе, C.trahomatis. Клиническая картина хламидиоза заболевания определяется видом возбудителя. Эффективность лечения зависит от своевременной и адекватной терапевтической тактики. Ключевые слова: хламидия, пневмония, инфекция.

https://doi.org/10.35339/ic.1.1.116-131
PDF

References

Aberle J.H. Single versus dual respiratory virus infections in hospitalized infants: Impact on clinical course of disease and interferon-response. / J.H. Aberle, S.W. Aberle, E. Pracher // Pediatric Infectious Disease Journal. – 2005. —V. 24. — P. 605–610.

About problem of chlamidiosis infection. / L.M. Sladkova, S.A. Rizenko, I.Yu.Stetsenko [et al.] // Annals of Mechnicov’s Institute. – 2005. — № 2. – P. 59 –63.

An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia. / P.I. Lee, M.H. Wu, L.M. Huang [et al.] // Journal of Microbiology, Immunology and Infection. – 2008. – P. 41–54.

Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. / L.A. Jackson, S.P. Wang, V. Nazar-Stewart [et al.] //Cancer Epidemiology, Biomarkers & Prevention.–2000. — V. 9. — P. 1263 – 1266.

Bennedsen M.Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies. / M.Bennedsen, Berthelsen L., I. Lind. // Clinical and Diagnostic Laboratory ImmunologyJournal.– 2002.– V. 9. — P. 833−839.

Blasi F.Chlamydia pneumoniae: crossing the barriers? / F. Blasi, S. Centanni, L. Allegra // European Respiratory Journal. – 2004. — V. 23. — P. 499–500.

Byrne G.I. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. / G.I. Byrne, D.M. Ojcius // Nature reviews. Microbiology Journal. – 2004. —V. 2. — P. 802 – 808.

Byrne G.I. Chlamydia uncloaked. / G.I. Byrne // Proceedings of the National Academy of Sciences Journal. – 2003. —V. 100— P. 8040–8042.

Characterization of Chlamydia isolated from human patients in Germany over a 3-year period. / L. Beutin, G. Krause, S. Zimmermann [et al.] // Journal of Clinical Microbiology. – 2004. – № 42. – P. 1099 – 1108.

Characterization of host cell death induced by Chlamydia trachomatis. / S. Ying, S.F. Fischer, M. Pettengill [et al.] // Infection and Immunity. — 2006. — V. 74. — P. 6057–6066.

Chlamydia Lung Infection / J. Rodrigues, C.M.Thomazini, A.Morelli [et al.] // Journal of Clinical Microbiology. – 2003. – № 42. – Р. 398 – 400.

Сhlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors. / N. H.Birkebaek, J. S. Jensen, T. Seefeldt [et al.] //European Respiratory Journal. —2000. —V. 16. — P. 108 —111.

Chlamydia pneumonia inhibitis apoptosis in human epithelial and monocyte cell lines./ S.Airenne, H.M.Surcel, J. Tuukkanen [et al.] // Scandinavian Journal of Immunology. – 2002. – V. 55. – №4. — P. 390−398.

Chlamydophila pneumoniae myopericarditis in a child. / M.Suesaowalak, M.M.Cheung, D. Tucker [et al.] // Pediatric Cardiology. — 2009. — 30. —P. 336.

Chlamydia (Chlamydophila) pneumoniae. / L.A. Jackson, G.L.Mandell, J.E.Bennett [et al.]. Principles and Practice of Infectious Diseases. – Philadelphia: Elsevier, 2005. — V. 6. — 205p.

Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study. / N.J. Wald, M.R. Law, J.K. Morris [et al.] // British Medical Journal. – 2000. – V. 321. – P. 204 – 207.

Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment./ J. Gieffers, H. Fullgraf, J. Jahn [et al.] // Circulation. – 2001. – № 103.– Р. 351–356.

Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis / G. Zandbergen, J. Gieffers, H. Kothe [et al.] // Journal of Immunology. — 2004. — V. 172. — P. 1768–1776.

Chlamydia pneumonia. / M.R. Hammerschlag,R.D.Feigin, J.D. Cherry [et al.]. Textbook of PediatricInfectious Diseases Journal.– Philadelphia:Elsevier, 2009.– V. 6.–1676p.

Chlamydia pneumoniae in children undergoing adenoidectomy. / E. Norman, J. Gnarpe, J. Naas [et al.] // Acta Paediatrica Journal. — 2007. — V. 90. — №2. — P. 126–129.

Chlamydia pneumonia in children. / D. Mahalanabis, A.S. Faruque, S.S. Hoque [et al.] // Acta Paediatrica Scandinavica Journal.– 2008. – №84. – Р. 289 – 293.

Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. / J. Rupp, T. Hellwig-Burgel, V. Wobbe [et al.] // Proceedings of the National Academy of Sciences of the United States of America. – 2005. – V. 102. – Р. 3447–3452.

Chlamydia polipeptide. / E. Salazar-Lindo, J. Santisteban-Ponte, E. Chea-Woo [et al.] // New England Journal of Medicine. – 2007. – V. 343. – P. 463–467.

Chlamydia pneumoniaserology: importance of methodology in patients with coronary heart disease and healthy individuals. / A. Schumacher, A.B. Lerkerod, I. Seljeflot [et al.] // Journal of Clinical Microbiology. —2001. — V. 39. — P. 1859–1864.

Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results. / R.W. Peeling, S.P. Wang, J.T. Grayston [et al.] // Journal of Infectious Diseases– 2000. – V. 181(3). — P. 426–429.

Chlamydophila (Chlamydia) pneumoniae infection of human astrocytes and microglia in culture displays an active, rather than a persistent, phenotype. / U. Dreses-Werringloer, H.C. Gerard, J.A.Whittum-Hudson [et al.] // American Journal of the Medical Sciences. – 2006. – V. 332. – Р. 168 – 174.

Chlamydia trachomatis respiratory infection in Dutch infants. / G.I. Rours, M.R. Hammerschlag, G.J. Van Doornum [et al.] // Archives of Disease in Childhood – 2009. – V. 94. – P. 705.

Choice S.G. Immunological cells in patients with Chlamydia pneumonia / S.G. Choice // Pediatrics Journal. – 2001. − № 107. – Р. 613 − 618.

Comparison of real-time PCR assays with fluorescent-antibody assays for diagnosis of respiratory virus infections in children./ J.Kuypers, N. Wright, J. Ferrenberg [et al.] //Journal of Clinical Microbiology. – 2006. – V. 44. – P. 2382–2388.

Comparison of Two Commercial Microimmunofluorescence Kits and an Enzyme ImmunoassayKit for Detection of Serum Immunoglobulin G Antibodies to Chlamydia pneumonia. / T.O. Messmer, J. Martinez, F. Hassouna [et al.] // Clinical and Vaccine Immunology. — 2007. — V. 8. —№3. — P. 588– 592.

Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques. / F. Cirino, W.C. Webley, C. West [et al.] // BMC Infectious DiseasesJournal. – 2006. – V. 6. – 23р.

Diagnosis of Chlamydia pneumoniain community-acquired pneumonia in children. / C. Hedberg, S. Savarino, J. Besser [et al.] //Journal of Infectious Diseases. – 2008. —№ 176. — P. 1625 − 1628.

"Inter Collegas" is an open access journal: all articles are published in open access without an embargo period, under the terms of the CC BY-NC-SA (Creative Commons Attribution ‒ Noncommercial ‒ Share Alike) license; the content is available to all readers without registration from the moment of its publication. Electronic copies of the archive of journals are placed in the repositories of the KhNMU and V.I. Vernadsky National Library of Ukraine.